SELENBP1 and breast cancer: Selenium-mediated inhibition of breast cancer growth was compared between the cell line with high endogenous SELENBP1 (MCF7 transfected with shRNA vector control) and SELENBP1 knock-down cells (MCF7 transfected with SELENBP1-specific shRNA).